# Linagliptin Response to OGTT in Prediabetes and Type 2 Diabetes Mellitus

> **NCT05290506** · PHASE3 · COMPLETED · sponsor: **National University of Malaysia** · enrollment: 50 (actual)

## Conditions studied

- PreDiabetes
- Type 2 Diabetes

## Interventions

- **DRUG:** Dipeptidyl-Peptidase IV Inhibitors

## Key facts

- **NCT ID:** NCT05290506
- **Lead sponsor:** National University of Malaysia
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-01
- **Primary completion:** 2021-03-01
- **Final completion:** 2021-03-01
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2022-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05290506

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05290506, "Linagliptin Response to OGTT in Prediabetes and Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05290506. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*